TAT GIDA SANAYİ A.Ş.

Share Issue/Capital Change • Dec 24, 2024

Summary Info	Dates for the Use of the Right to Purchase New Shares in the Paid-in Capital Increase
Update Notification Flag	No
Correction Notification Flag	Yes
Postponed Notification Flag	No
Reason of Correction	There is no any correction.

Board Decision Date	09.08.2024
Authorized Capital (TL)	250.000.000
Paid-in Capital (TL)	136.000.000
Target Capital (TL)	244.800.000

Rights Issue (Via Preemptive Right)

Share Group Info	Paid-in Capital (TL)	Preemptive Rights Amount (TL)	Preemptive Rights Rate (%)	Preemptive Rights Price	Share Group Issued	New Shares'' ISIN	Form	Preemptive Rights ISIN Code	Unused Rights Amount (TL)	Amount of Shares Cancelled (TL)
TATGD, TRATATKS91A5	136.000.000	108.800.000,000	80,00000	1,00		TATGD, TRATATKS91A5	Registered	TATGD(RÜÇHAN), TRRTATK00026

	Paid-in Capital (TL)	Preemptive Rights Amount (TL)	Preemptive Rights Rate (%)	Unused Rights Amount (TL)	Amount of Shares Cancelled (TL)
TOTAL	136.000.000	108.800.000,000	80,00000

Explanation About The Shares Not Sold	There are no commitments regarding the acquisition of shares that cannot be sold.
Rights Issue Ex-Date	26.12.2024
Preemptive Rights Exercise End Date	09.01.2025
Currency Unit	TRY

Other Aspects To Be Notified

Capital Market Board Application Date	14.08.2024
Capital Market Board Application Result	Approval
Capital Market Board Approval Date	20.12.2024
Property of Increased Capital Shares	Dematerialized Share
Payment Date	30.12.2024
Record Date	27.12.2024

Additional Explanations

Our capital increase application which is regarding the issuance of shares with a nominal value of TRY 108,800,000 due to the increase in our Company's issued capital from TRY 136,000,000 to TRY 244,800,000 within the registered capital ceiling of TRY 250,000,000, with TRY 108,800,000 in cash, was approved by the Capital Markets Board at its 20.12.2024 dated meeting and it was published in the CMB Bulletin dated 20.12.2024 and numbered 2024/57.

The prospectus approved by CMB has been published on Public Disclosure Platform.

The rights to acquire new shares will be allowed to be exercised for 15 days between 26.12.2024 and 09.01.2025 in accordance with the principles specified in the prospectus.

Shareholders have the right to acquire new shares at a rate of 80% according to their current shares in the issued capital. Shareholders who do not wish to exercise their right to acquire new shares may sell these rights within the Preemptive Right Coupon Market period. In order for the right to acquire new shares (preemptive) to be bought and sold, the Preemptive Right Coupon Market is opened by the Stock Exchange and announced on the Public Disclosure Platform. The opening day of the Preemptive Right Coupon Market is the starting day of the preemptive right exercise. The closing (last transaction) day of the Preemptive Right Coupon Market is the fifth business day before the end of the preemptive right exercise period.

In the exercise of the rights to acquire new shares, shares with a nominal value of TL 1.00 will be offered for sale for a price of TL 1.00.

Our partners who want to use their new share purchase rights will apply to the brokerage houses where they have investment accounts and deposit the new share purchase prices. The share prices will be deposited in full and in cash into the investment accounts at the brokerage houses to be transferred to the TR670006701000000023654379 IBAN numbered account opened at Yapı ve Kredi Bankası A.Ş. exclusively for use in this capital increase.

The Prospectus approved by the Board regarding the capital increase is also available on the websites of the Public Disclosure Platform (KAP) at www.kap.org.tr, Tat Gıda Sanayi A.Ş. at www.tatgida.com.tr and Tera Yatırım Menkul Değerler A.Ş., which will mediate the sales in the public offering, at www.terayatirim.com

The shares to be issued will be monitored by the CRA on a per-rights basis within the framework of the principles of registration, and the physical delivery of the shares will not be made. The registered shares will be delivered in registers within the framework of the CRA regulations following the use of the rights during the right use period.

The shares remaining after the exercise of the rights to acquire new shares (preemptive rights) will be offered to the public at the price to occur on the Stock Exchange Primary Market, without falling below the nominal value for 2 business days.

There are no commitments regarding the acquisition of shares that cannot be sold.

This statement was translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.